Fagron NV 2024 AR2
The report highlights Fagron's strong financial and operational performance in 2024, with revenue increasing by 14.3% to 872.0 million euros and net profit rising by 14.0% to 81.0 million euros. The company launched its 'Future Forward: Personalizing Medicine' sustainability strategy, integrating ESG goals across its operations, people, and compounding pillars. Notably, Fagron achieved validation of its science-based emission reduction targets by the SBTi and reduced its Scope 1 and 2 emissions by 26% compared to the 2021 baseline. Additionally, the company expanded its global footprint through strategic acquisitions, including EuroOTC in Germany and Parma Produkt in Hungary.
Company: Fagron NV
Sector: Health Care
Country: Belgium
Year: 2024
Type: AR2
Pages: 254
Fagron NV
Annual Report
The report highlights Fagron's strong financial and operational performance in 2024, with revenue increasing by 14.3% to 872.0 million euros and net profit rising by 14.0% to 81.0 million euros. The company launched its 'Future Forward: Personalizing Medicine' sustainability strategy, integrating ESG goals across its operations, people, and compounding pillars. Notably, Fagron achieved validation of its science-based emission reduction targets by the SBTi and reduced its Scope 1 and 2 emissions by 26% compared to the 2021 baseline. Additionally, the company expanded its global footprint through strategic acquisitions, including EuroOTC in Germany and Parma Produkt in Hungary.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees